Is XBiotech Inc. (XBIT) A Good Stock To Buy?
At Insider Monkey, we pore over the filings of nearly 817 top investment firms every quarter, a process we have now completed for the latest reporting period. The data we've gathered as a result gives...
Xbiotech Inc. (XBIT) - News
Get Email Alerts News
- Displaying 8
Hedge Fund and Insider Trading News: Warren Buffett, Mike Novogratz, Citadel LLC, Marble Ridge Capital, Amber Capital, Flotek Industries Inc (FTK), Salesforce.com, Inc. (CRM), and More
Arnaud Lagardere is learning the hard way that marriages of convenience in the business world can work for you, and against you. The hedge fund Amber Capital U.K. LLP has for two years been targeting...
Hedge Funds Starting To Get Bullish On XBiotech Inc. (XBIT)
In this article we will check out the progression of hedge fund sentiment towards XBiotech Inc. (NASDAQ:XBIT) and determine whether it is a good investment right now. We at Insider Monkey like to examine...
XBiotech Inc. (XBIT): Are Hedge Funds Right About This Stock?
"The global economic environment is very favorable for investors. Economies are generally strong, but not too strong. Employment levels are among the strongest for many decades. Interest rates are paused...
Hedge Fund and Insider Trading News: Whitney Tilson, Carl Icahn, Elliott Management, Entercom Communications Corp. (ETM), Hain Celestial Group Inc (HAIN), and More
Badly burned by engines that set fire, and under fire from hedge-fund veteran Paul Singer, Hyundai Motor (HYMTF) finds itself under attack on all sides. The Hong Kong arm of Elliott Management on Monday...
These 34 Stories Can Tell You What’s Happening In The Finance World Today
"U.S. stocks recovered from lows of the day Friday afternoon, but were struggling to trade in positive territory, as President Donald Trump’s said a much-awaited tax-reform plan was imminent. However...
XBiotech Inc. (XBIT) Rolls Off 40% Amid Negative Trend Vote on Marketing Application of Cancer-treating Antibody
XBiotech Inc. (NASDAQ:XBIT) rolled off 40.04% or $6.82 to $10.20 per share on April 21, after announcing that its marketing authorization application (MAA) related to its candidate antibody for treating...
Here’s Why The XBiotech Inc (XBIT) Data Is So Important
At the end of May, we [Market Exclusive] published this piece discussing a then-upcoming data presentation from Texas based biotech, XBiotech Inc (NASDAQ:XBIT). We noted that the data had the potential...
Billionaire Hedge Funds
